Research Article
The Association of Thyroid Nodules with Metabolic Status: A Cross-Sectional SPECT-China Study
Table 2
Prevalence of TN and US characteristics (%) according to the status of metabolic diseases.
| | Men | Women | TN | Microcalcification | Taller-than-wide shape | TN | Microcalcification | Taller-than-wide shape |
| Met-S | 48.2 | 2.3 | 1.5 | 67.6 | 1.0 | 3.3 | Without Met-S | 39.6 | 1.0 | 1.9 | 52.3 | 0.9 | 2.1 | value | <0.001 | 0.073 | 0.596 | <0.001 | 0.731 | 0.102 | Obesity | 46.9 | 1.1 | 2.8 | 66.0 | 0.8 | 4.1 | Without obesity | 40.2 | 1.4 | 1.8 | 55.0 | 1.0 | 2.2 | value | 0.001 | 0.646 | 0.222 | <0.001 | 0.696 | 0.007 | Central obesity | 47.1 | 1.6 | 2.5 | 65.0 | 1.2 | 3.4 | Without central obesity | 39.0 | 1.2 | 1.6 | 50.2 | 0.7 | 1.6 | value | <0.001 | 0.498 | 0.207 | <0.001 | 0.210 | 0.003 | Diabetes | 50.3 | 0.8 | 1.6 | 69.5 | 1.5 | 3.9 | Without diabetes | 39.7 | 1.5 | 2.1 | 54.7 | 0.9 | 2.2 | value | <0.001 | 0.371 | 0.550 | <0.001 | 0.318 | 0.086 | Hyperlipidaemia | 45.3 | 1.7 | 2.5 | 64.7 | 1.2 | 2.5 | Without hyperlipidaemia | 38.3 | 1.0 | 1.6 | 52.5 | 0.9 | 2.5 | value | <0.001 | 0.276 | 0.168 | <0.001 | 0.361 | 0.733 | Hypertension | 45.8 | 1.3 | 1.9 | 66.1 | 1.3 | 2.6 | Without hypertension | 36.3 | 1.4 | 2.3 | 49.6 | 0.8 | 2.4 | value | <0.001 | 0.806 | 0.576 | <0.001 | 0.168 | 0.572 | NAFLD | 44.8 | 1.3 | 2.0 | 63.5 | 1.5 | 3.8 | Without NAFLD | 38.3 | 1.0 | 2.3 | 54.0 | 0.8 | 2.0 | value | <0.001 | 0.650 | 0.699 | <0.001 | 0.084 | 0.008 |
|
|
Met-S: metabolic syndrome; NAFLD: nonalcoholic fatty liver disease.
|